KC
MDT icon

Kinloch Capital’s Medtronic MDT Stock Holding History

Kinloch Capital’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.63M Sell
41,949
-843
-2% -$80.8K 1.48% 36
2025
Q4 		$4.11M Buy
42,792
+345
+0.8% +$33.5K 1.77% 22
2025
Q3 		$4.04M Buy
42,447
+296
+0.7% +$27.2K 1.77% 24
2025
Q2 		$3.67M Buy
42,151
+541
+1% +$45.9K 1.71% 28
2025
Q1 		$3.74M Sell
41,610
-78
-0.2% -$6.98K 1.79% 23
2024
Q4 		$3.33M Buy
41,688
+1,225
+3% +$106K 1.67% 33
2024
Q3 		$3.64M Buy
40,463
+101
+0.3% +$8.5K 1.77% 30
2024
Q2 		$3.18M Sell
40,362
-718
-2% -$58.9K 1.66% 31
2024
Q1 		$3.58M Buy
41,080
+1,878
+5% +$160K 1.84% 27
2023
Q4 		$3.23M Sell
39,202
-832
-2% -$63.4K 2.05% 20
2023
Q3 		$3.14M Sell
40,034
-141
-0.4% -$11.8K 1.96% 21
2023
Q2 		$3.54M Sell
40,175
-661
-2% -$56.9K 2.11% 16
2023
Q1 		$3.29M Sell
40,836
-9,215
-18% -$751K 1.92% 24
2022
Q4 		$3.89M Buy
+50,051
New +$4.06M 2.26% 10

Other funds holding MDT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Kinloch Capital's MDT Position: Q1 2026 in Review

Kinloch Capital reduced its Medtronic (MDT) stake by 2% in Q1 2026, selling an estimated $80.8K and leaving 41,949 shares worth $3.63M. The position accounts for 1.48% of the portfolio, ranked #36.

Kinloch Capital first reported a position in MDT in Q4 2022 and has held it in 14 quarters since. The position peaked at $4.11M in Q4 2025. 2,231 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Kinloch Capital held 41,949 shares of Medtronic worth $3.63M as of Q1 2026.
  • Kinloch Capital sold 843 Medtronic shares in Q1 2026, an estimated $80.8K.
  • Medtronic made up 1.48% of Kinloch Capital's portfolio in Q1 2026, its #36 holding.
  • Kinloch Capital first reported a position in Medtronic in Q4 2022 and has held it in 14 quarters since.
  • Kinloch Capital's Medtronic position peaked at $4.11M in Q4 2025.
  • 2,231 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Kinloch Capital's 13F filing for Q1 2026, filed 15 May 2026.